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Novel pyrazole chalcone has been synthesized by reaction of phenyl-3-p-tolyl-1H-pyrazole-4-carbaldehyde and 
acetophenone by Claisen-Schmidt reaction in ethanol by microwave assisted method. It has been characterized by elemental 
analysis and spectroscopic (FTIR, 1H NMR and MS) studies. Crystal structure of the compound has been determined using 
single-crystal X-ray diffraction. Hydrogen-bonded chain is formed by C–H···O bonding enhanced by C–H···π interaction. 
Adjacent chains are connected through the π···π interactions. 
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Chalcones represent an important class of molecules. 
It shows presence of an electron donor and electron 
acceptor group. Phenyl substituents are electron 
donors, whereas carbonyl groups act as electron 
acceptors. The aromatic ketone group and enone 
group in chalcones makes it more active. Chalcones 
are useful for the preparation of biologically and 
industrially important compounds1. They are found 
abundantly in edible plants of species Leguminosae, 
Asteraceae, Moraceae, etc.2 Chalcones comprise of a 
class of compounds with important therapeutic and 
pharmacological potential. It’s easy preparation and 
great potential of oral administration3 support the 
feasibility of chalcone-based compounds as 
therapeutic agents. Chalcone and its derivatives show 
diverse medicinal properties including anti-
inflammatory4, immunomodulatory5, anticancer6, anti-
HIV7, antiproliferative8, and α-glucosidase inhibitory 
activities9. Some pyrazole derivatives show antiviral 
activity against Herpes infections10. Chalcones are 
also used as precursors in the biosynthesis of 
flavonoids11 and isoflavonoids12. 
 
Experimental Section 
Material and Method 
All the starting materials and solvents were 
purchased from commercial sources and were used 
without further purification. Microwave oven of 
SAMSUNG, 800W output with digital timer and 
clock was used for synthesis. Melting points were 
determined in open capillaries using Electro thermal 
melting point apparatus and are uncorrected. Progress 
of reactions was monitored by TLC. Infrared (IR) 
spectra (4000–600 cm−1) of the samples were 
recorded using a Perkin–Elmer Spectrum 100, 
equipped with a Specac Golden Gate Diamond ATR 
as a solid sample support. 1H NMR spectra were 
recorded with a BrukerAvance III 500 NMR 
spectrometer with TMS as internal reference. MS 
spectra were recorded with an Agilent 6624 Accurate 
Mass TOF LC/MS instrument (ESI ionization). Elemental 
(C, H, N) analyses were obtained using Perkin–Elmer 
2400 Series II CHNS/O Elemental Analyzer. 
 
Synthesis of 1-phenyl-3-p-tolyl-1H-pyrazole-4-carbal- 
dehyde, 3:  
A mixture of 4-methylacetophenone 1 (1.34 g,  
10.0 mmol), phenylhydrazine (1.08 g, 10.0 mmol), 1 drop 
of conc. HCl and ethanol as a solvent was taken in a 
100 mL conical flask and irradiated in microwave 
oven for 10-20 s at 450 watt at an interval of 5 second 
each. The resultant dry solid 2 was dissolved in 
excess of DMF, followed by addition of 15 mmol of 
POCl3 with continuous stirring in cold condition at 
about 8° to 10°C. The reaction mixture was allowed 
to attain RT and heated at about 80°C for 1 h 
conventionally. On hydrolysis it gave off white 
colored solid. The solid obtained was washed with 
water to remove excess of HCl, filtered, dried and 
recrystallized using ethanol. The recrystallized 
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compound was kept for crystal growth by slow 
evaporation of saturated solution of compound in 
mixture of ethanol and chloroform (1:1 v/v) in a dark 
chamber at low temperature13. Yield 89%. m.p.100°C. 
IR: 3125 (Ar-CH), 2838 (C–H in CHO), 1673 (C=O), 
1518 (C=N), 1450 cm–1 (C=C); 1H NMR (500 MHz, 
CDCl3): δ 2.36 (s, 3H, Ar-CH3), 7.23-7.25 (d, 2H, Ar-
H), 7.30-7.33 (t, 1H, Ar-H), 7.42-7.45 (t, 2H, Ar-H), 
7.62-7.63 (d, 2H, Ar-H), 7.71-7.73 (d, 2H, Ar-H), 
8.46 (s, 1H, pyrazole-CH), 9.98 (s, 1H, –CHO). 
 
Synthesis of 1-phenyl-3-(1-phenyl-3-p-tolyl-1H-
pyrazole-4-yl)prop-2-en-1-one, 4:  
A mixture of phenyl-3-p-tolyl-1H-pyrazole-4-
carbaldehyde (2.62 g, 10 mmol), acetophenone (1.20 g, 
10 mmol) and 2–3 drops of saturated NaOH solution 
was subjected to microwave irradiation in presence of 
ethanol as a solvent for 1–2 min at 450 watt at an 
interval of 5 second each. The dark yellow solid so 
obtained was added to crushed ice followed by 
acidification using 0.1 M HCl to give pale yellow 
solid. The product obtained was filtered, dried and 
recrystallized using ethanol. The recrystallized 
compound was allowed for crystal growth by slow 
evaporation of its saturated solution with mixture of 
ethanol and chloroform (1:1 v/v) in a dark chamber at 
low temperature. Yield 79%. m.p.140°C. IR: 3117 
(CH=CH), 3066 (Ar-CH), 1643 (C=O), 1539(C=N), 
1448 (C=C), 831 cm–1 (Ar-CH3); 1H NMR (500 MHz, 
CDCl3): δ 2.36 (s, 3H, Ar-CH3), 7.18 (s, 2H, Ar-H), 
7.23 (d, 2H, Ar-H), 7.30 (s, Ar-H), 7.40-7.44 (m, 4H, 
Ar-H), 7.48 (d, 1H, CH=CH), 7.72 (d, 2H, Ar-H), 
7.81 (d, 1H, CH=CH), 7.89 (d, 2H, Ar-H), 8.27 (s, 
1H, pyrazolic CH); MS (ESI+): m/z 365 (MH+); 
HRMS: Calcd for C25H21N2O: 365.1648. Found: 
365.1648. Anal. Calcd for C25H20N2O (364.43 g/mol): 
C, 82.39; H, 5.53; N, 7.69. Found: C, 81.69; H, 5.31; 
N, 7.35%. 
 
X-ray crystallographic study 
Single-crystal X-ray diffraction data was  collected on 
an Agilent Technologies SuperNova Dual diffractometer 
with an Atlas detector using monochromated Cu-Kα 
radiation (λ = 1.54184 Å) at RT. The data was  
processed using CrysAlis Pro14. Structure was solved by 
charge-flipping methods implemented in Superflip15 and 
refined on F2 using full-matrix least-squares procedures 
using SHELX201416. All non-hydrogen atoms were 
refined anisotropically. Hydrogen atoms were readily 
located in a difference Fourier maps and were 
subsequently treated as riding atoms in geometrically 
idealized positions, with C–H = 0.93 (aromatic and 
alkenyl) or 0.96 Å (methyl) with Uiso(H) = kUeq(C), 
where k = 1.5 for methyl groups, which were permitted 
to rotate but not to tilt, and 1.2 for all other H atoms. 
CCDC 1848478 contains the supplementary 
crystallographic data for this paper. This data is provided 
free of charge by The Cambridge Crystallographic Data 
Centre. Crystallographic data is listed in Table I. 
 
Results and Discussion 
The compound 1-phenyl-3-(1-phenyl-3-p-tolyl-1H-
pyrazole-4-yl)prop-2-en-1-one 4 was obtained by 
microwave assisted Claisen-Schmidt reaction between 
acetophenone and 1-phenyl-3-p-tolyl-1H-pyrazole-4-
carbaldehyde 3 (Scheme I). The IR spectrum of 
compounds 3 showed characteristic υ(-CH=O) 
absorption band in the region 1660–1677 cm−1, and 
υ(-C=N) band in the region 1513–1522 cm−1. The 
1H NMR spectra of compounds 3 in CDCl3 exhibit 
characteristic singlet at 9.95–9.99 ppm attributed  
to –CH=O protons, singlet at 8.46–9.28 ppm is 
Table I — Crystallographic data for 4 
Compd code 4 
CCDC number 1848478 
Molecular formula C25H20N2O 
Molecular weight 364.43 
Crystal System Monoclinic 
Space group P21/c 
a (Å) 12.7305(4) 
b (Å) 15.5517(5) 
c (Å) 10.9948(4) 
α (°) 90 
β (°) 110.267(4) 
γ (°) 90 
Z 4 
V (Å3) 2041.99(13) 
Dcalc (g cm–3) 1.185 
μ (mm–1) 0.570 
F(000) 768 
Reflections collected 7919 
Independent reflections 3874 
Rint 0.0216 
Parameters 255 
R1, wR2 [I> 2σ(I)]a 0.0463, 0.1300 
R1, wR2 (all data)a 0.0575, 0.1442 
GOFb 1.036 
Δρmin, Δρmax (e Å–3) 0.174, –0.136 
aR = ∑||Fo| – |Fc||/∑|Fo|; wR2 = {∑[w(Fo2 – Fc2)2]/∑[w(Fo2)2]}1/2. 
bS = {∑[(Fo2 – Fc2)2]/(n/p)}1/2 where n is the number of 
reflections and p is the total number of parameters refined. 
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attributed to pyrazolic –CH protons. The IR spectrum 
of compounds 4 shows characteristic absorption band 
at 3117 cm−1 representing olefinic stretching and at 
1643 cm−1attributed to ketonic C=O group. 
Absorption band in the region 1539 cm−1 represents 
pyrazolic N–N bond. The 1H NMR of compound 4 
exhibit characteristic singlet at 2.36 ppm attributed to 
three protons of CH3 in tolyl ring, singlet at 8.27 ppm 
attributed to pyrazolic CH, doublet at 7.48 ppm and 
7.81 ppm, respectively, representing CH=CH of 
chalcone moiety. Furthermore, the mass spectra and 
elemental analysis support the structure of  
compound 4.  
Single crystal structure of compound 4 shows that 
all the bond lengths are within normal ranges 
(Figure 1)17. In the compound the pyrazole ring 
N1/N2/C10–C12 is essentially planar with the 
maximum deviation from planarity of –0.003 (2) for 
atom C 11. Also, the pyrazolylphenylpropenone 
backbone is almost planar with the dihedral angle 
between pyrazole ring and the phenyl ring C4-C9 of 
7.63 (10)°. Similar small dihedral angle of 7.54 (11)° 
is present also between the pyrazole ring and the 
phenyl ring C13–C18. On the other hand, the dihedral 
angle between pyrazole and tolyl ring C19–C24 is 
much larger being 32.95 (9)°. 
Supramolecular structure of the studied compound 
is achieved through a hydrogen-bonded chain formed 
by C12–H12···O1 bonding between the pyrazole CH 
moiety as a hydrogen-bond donor and the carbonyl O 
atom as a hydrogen-bond acceptor forming a C(7) 
graph set motif18. (Table II, Figure 2). This chain is 
further enhanced by a C23–H23···π interaction 
between the tolyl CH moiety and pyrazole ring. 
Adjacent chains are connected through the π···π 
interactions between pyrazole ring and phenyl ring 
C13–C18 with centroid-to-centroid distance of 3.9714 
(12) Å, and dihedral angle between the rings of 7.54 
(11)° and this 2D motif is further enhanced by  
C21–H21·π interactions between the tolyl CH moiety 
and the phenyl C4–C9 ring. 
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Scheme I — Synthesis of 1-phenyl-3-(1-phenyl-3-p-tolyl-1H-pyrazole-4-yl)prop-2-en-1-one 
 
 
Figure 1 — Molecular structures and atom numbering scheme for
4. Probability ellipsoids are drawn at the 50% level 
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Conclusion 
Novel pyrazole chalcone was synthesized by 
microwave assisted Claisen-Schimdt condensation 
reaction with good yield. Spectroscopic analysis and 
single crystal study proves the formation of desired 
compound. In the crystal structure hydrogen-bonded 
chain is formed by C12–H12···O1 bonding enhanced 
by a C23–H23···π interaction. Adjacent chains are 
connected through the π···π interactions. 
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Figure 2 — (a) Chain formation generated by C12–H12···O1
hydrogen bonding (blue dashed lines) and C23–H23···π
interactions (black dashed lines). Hydrogen atoms not involved in
the motif shown have been omitted for clarity. (b) π···π
interactions between pyrazole and phenyl rings (black dashed
lines). (c) Packing of hydrogen-bonded chains along c-axis. 
Table II — Hydrogen bond geometry of 4 
D–H·A D–H (Å) H·A (Å) D·A (Å) D–H·A (°) Symmetry code 
C12–H12·O1  0.93 2.38 3.308(2) 174 x, 3/2 – y, ½ + z 
C21–H21·Cg2 0.93 3.00 3.775(2) 142 –x, ½ + y, ½ – z 
C23–H23·Cg1 0.93 2.83 3.593(2) 140 x, 3/2 – y, –½ + z 
Cg1 and Cg2 are N1/N2/C10–C12 and C4–C9 ring centroids, respectively. 
